1 year return (CAGR)
14.49%
OncoCyte Corp Exchange (NASDAQ, USD)
OCX
-
-0.04 (-1.25%)
HealthcareDiagnostics & Research
Loading...
3 year return (CAGR)
-47.94%
5 year return (CAGR)
-41.62%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
90.37M
Price/Sales
127.47
Ent value
147.52M
Price/Book
9.31
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-15.29%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 3.04 |
| Daily high | 3.23 |
| Daily low | 2.76 |
| Daily Volume | 1.44M |
| 1y analyst estimate | 5.42 |
| Beta | 0.99 |
| EPS (TTM) | -3.15 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| OCX | S&P500 | |
| Current price drop from All-time high | -98.44% | -2.53% |
| Highest price drop | -99.03% | -56.47% |
| Date of highest drop | 22 Jan 2025 | 9 Mar 2009 |
| Avg drop from high | -75.47% | -10.68% |
| Avg time to new high | 595 days | 12 days |
| Max time to new high | 2378 days | 1805 days |
News
No items found